Abstract 5502: Oral Anticoagulation Monotherapy versus Combination Antithrombotic Therapy with Antiplatelet Following TAVR in Patients on Chronic Oral Anticoagulation
Introduction: Optimal antithrombotic management following transcatheter aortic valve replacement (TAVR) in patients with pre-existing indications for chronic oral anticoagulation (OAC) remains poorly defined. Current evidence, including the POPular TAVI trial, suggests OAC monotherapy may be sufficient, yet combinat...